Danish Headache Center
Glostrup Municipality, 2600, Denmark
NCT Number: NCT03626805
The aim of the study is to examine symptomatology, quantitative sensory test (QST) parameters, muscle tenderness and muscle hardness in migraine patients interictally and compare with healthy controls
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Glostrup Municipality, 2600, Denmark
Migraine patients exhibit different symptomatology and responses to treatment. For example do many migraine patients have neck symptoms, despite they apparently do not have any neck disorders.Furthermore the response to treatment differs between patients. Differences in symptomatology, QST parameters and muscle stiffness can be used to subdivide and phenotype migraine patients.
The investigators are examining migraine patients with:
A semistructured interview, Quantitative sensory testing (cold pain threshold, heat pain threshold and Pin Prick), Muscle tenderness (total tenderness score, local tenderness score and stimulus response curve), and muscle hardness with ultrasound elastography. All tests are performed the same day
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Healthy controls:
Exclusion criteria
Time frame: 3 hours
We would like to examine the relationship between the variable variable: Neck stiffness during migraine attack (Yes/No) and the Independent variables: Total Tenderness Score (summed score from 8 points bilateral, each point can score 0-3), Migraine localisation (occipital: Yes/No), Tension Type Headache, Allodynia (yes/No), Stimulus response curve (Pressure and Pain).
The result shows how much of the variability in neck stiffness that can be explained by the independent variables.
Time frame: 3 hours
We will examine whether patients with neck stiffness during migraine attack (yes/no) have higher tenderness scores compared to patients without neck stiffness during migraine attacks, when correcting for headache frequency.
Time frame: 3 hours
Muscle hardness (m/s) in migraine patients compared to healthy controls.corrected for age, BMI and sex
Time frame: 3 hours
Muscle hardness (m/s) in migraine patients with neck stiffness during migraine attacks compared to migraine patients without neck stiffness during migraine attacks. Corrected for age, BMI and sex.
Time frame: 3 hours
We would like to examine the relationship between the dependent variable: Total Tenderness Score(summed score from 8 points bilateral, each point can score 0-3), and the Independent variables: Neck Pain in general(Yes/No), Migraine localisation (occipital: Yes/No), Headache Frequency(days/month), Allodynia (Yes/No), Years with Migraine(Number of years)
Time frame: 3 hours
We would like to examine the relationship between the variable variable: Neck pain in general (Yes/No) and the independent variables: Tension Type Headache(yes/no), Migraine localisation, Headache Frequency(Headache days/month), Allodynia(yes/No), Years with Migraine(number of years)
Time frame: 3 hours
Using the prospective diary, we will examine the relationship between pericranial muscle tenderness and the next migraine attack, when correcting for headache frequency
Time frame: 3 hours
Muscle hardness will be measured with ultrasound elastography. Headache frequency is self-reported
Time frame: 3 hours
Muscle hardness will be measured with ultrasound elastography.
Time frame: 3 hours
Muscle hardness will be measured with ultrasound elastography
Danish Headache Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04220606
Brain Diseases, Central Nervous System Diseases
View Trial DetailsNCT02910921
Alzheimer Disease, Brain Diseases
Scottsdale, Arizona, United States
View Trial DetailsNCT07340788
Amino Acids, Peptides, and Proteins, Amylin
Glostrup Municipality, Denmark
View Trial DetailsNCT03472092
Brain Diseases, Central Nervous System Diseases
Cincinnati, Ohio, United States
View Trial Details